AGMB · Agomab Therapeutics NV · Debt
Market Cap
$655.49M
Shares
49.25M
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
24 filings
24 filers
Visit website
Investor relations